Gynecology Topic 12. Hormonal contraception. Intrauterine devices
I. Basic Concepts and Effectiveness
Pearl Index
- Pearl index: number of contraceptive failures/pregnancies per 100 women-years of use.
- Lower Pearl index → higher contraceptive effectiveness.
- Examples: OCP 0.1-2.5, postcoital pill 0.5-2.5, IUD 0.5-5, condom 3-28 in classic exam notes.
- LARC: IUDs and subdermal implant → high efficacy, low compliance burden, reversible.
Before Prescribing / Inserting
- History: thrombosis, migraine with aura, smoking, HT/CVD, liver disease, breast cancer, abnormal bleeding, medications, pregnancy risk.
- Measure BP before combined hormonal contraception; exclude pregnancy if uncertain and before IUD insertion.
II. Combined Hormonal Contraceptives
Definition and Mechanism
- Combined hormonal contraceptives (CHC): estrogen + progestin.
- Estrogen examples: ethinylestradiol, estradiol.
- Progestin examples: desogestrel, drospirenone, levonorgestrel, norethisterone.
- Mechanism: negative feedback on GnRH/FSH/LH → no follicle maturation + no LH surge → ovulation inhibition.
- Additional effects: thick cervical mucus → blocks sperm; endometrial changes.
Forms and Regimens
- Combined oral contraceptive pill (OCP): daily oral use; classic regimen = 21 active pills + 7 placebo/pill-free days.
- Monophasic OCP: fixed estrogen-progestin dose through active pills.
- Multiphasic OCP: biphasic/triphasic dose changes → lower total hormone exposure/cycle control.
- Transdermal patch: estrogen + progestin; apply weekly for 3 weeks → 1 patch-free week; abdomen, buttock, upper arm, upper torso.
- Vaginal ring: estrogen + progestin; inserted for 3 weeks → removed for 1 week; steady vaginal absorption.
Benefits and Indications
- Contraception with good cycle control.
- Non-contraceptive uses: dysmenorrhea, PMS/PMDD, endometriosis, PCOS/hirsutism/acne, heavy bleeding.
- Risk reduction: ovarian, endometrial and colorectal cancer.
Adverse Effects and Contraindications
- Common side effects: nausea, breast tenderness, breakthrough bleeding, headache, mood change, mild BP increase.
- Serious estrogen-related risks: venous thromboembolism, stroke/MI and hypertension.
- Contraindications: unexplained vaginal bleeding, current breast cancer, severe liver disease, previous/current thromboembolism or thrombophilia, stroke/ischemic heart disease, migraine with aura, smoker age ≥35 years, severe uncontrolled HT.
- Enzyme-inducing drugs may lower efficacy: rifampicin, phenytoin, carbamazepine, barbiturates.
III. Progestin-Only and Emergency Contraception
Progestin-Only Methods
- Main indication: when estrogen is contraindicated or undesirable, e.g. lactation, thromboembolic/cardiovascular risk, smoker age >= 35 years.
- Mechanism: thick cervical mucus; variable ovulation suppression; endometrial thinning/atrophy.
- Progestin-only pill / minipill: taken every day without hormone-free interval; same-time adherence is important.
- DMPA / Depo-Provera: depot medroxyprogesterone acetate IM every 3 months; useful for low compliance.
- DMPA side effects: irregular bleeding/amenorrhea, weight gain, delayed return of ovulation, reversible bone mineral density decrease.
- Subdermal implant: etonogestrel rod in upper arm/biceps groove; product duration varies, classic notes often list 5 years.
- General progestin side effects: irregular bleeding, acne, breast tenderness, headache, weight change.
Emergency Contraception
- Use: after unprotected intercourse or contraceptive failure.
- Levonorgestrel: 1.5 mg PO as soon as possible, best within 72 h.
- Ulipristal acetate: 30 mg single dose up to 120 h.
- Copper IUD: most effective emergency contraception; insert within 5 days after unprotected intercourse/estimated ovulation.
- Mechanism of emergency pills: delay/inhibit ovulation; they do not interrupt an established pregnancy.
IV. Intrauterine Devices
General Advantages
- IUDs: long-acting reversible contraception with very low failure rate and no daily user compliance issue.
- Advantages: low systemic side effects, removable anytime, rapid fertility return after removal.
Copper IUD
- Mechanism: copper ions + sterile endometrial inflammatory response → toxic to sperm/egg, impairs sperm motility and fertilization.
- Duration: commonly 10 years, depending on product.
- Advantages: hormone-free; also emergency contraception.
- Side effects: heavier bleeding, longer menses, increased dysmenorrhea/cramps.
Levonorgestrel IUD / Intrauterine System
- Mechanism: levonorgestrel → thick cervical mucus + endometrial atrophy → prevents fertilization; mainly local hormone effect.
- Duration: classic notes often list 5 years; current duration varies by product.
- Bleeding pattern: irregular spotting initially → lighter periods or amenorrhea later.
- Clinical uses: heavy menstrual bleeding, dysmenorrhea, endometrial protection/treatment in selected cases, endometriosis symptom control.
- Contraindication specific to LNG-IUD: current breast cancer.
IUD Contraindications and Complications
- Contraindications: pregnancy, unexplained bleeding, acute pelvic/cervical infection, postpartum/postabortal sepsis, distorted uterine cavity, genital tract malignancy.
- Insertion complications: pain, bleeding, vasovagal reaction, uterine perforation, failed insertion.
- Later complications: expulsion, missing strings, endometritis/salpingitis/PID, tubo-ovarian abscess, ectopic pregnancy if contraception fails.
Exam focus: CHC = estrogen + progestin → no FSH/LH surge and thick mucus, but thromboembolism risk limits use. Progestin-only methods are useful in lactation and estrogen contraindication. IUDs and implants are LARC methods with low user failure. Copper IUD causes sterile inflammatory spermicidal effect; LNG-IUD thickens mucus and atrophies endometrium.
Examiner focus
Nagy's Favorite Questions
Long-term OCP use - benefits
- Decreased ovarian/endometrial cancer, decreased bone loss, decreased dysmenorrhea, acne improvement, decreased risk of trisomies with increased maternal age, cycle regulation.
Long-term OCP use - risks
- Increased DVT/stroke, increased BP, weight gain, depression.
Pearl index
- Number of pregnancies in 100 females/year with chosen contraceptive.
Pearl index examples
- OCP 0.1-2.5; post-coital pill 0.5-2.5; IUD 0.5-5; condom 3-28; sterilization 0.3-6.